Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2012
03/15/2012WO2012033462A1 Molecular interaction between xa10 and avrxa10
03/15/2012WO2012033352A2 Equine amniotic fluid derived multipotent stem cells and a production method therefor
03/15/2012WO2012033328A2 Mdck-derived cell lines adapted to serum-free culture and suspension culture and method for preparing vaccine virus using the cells
03/15/2012WO2012033236A1 Mdck cell line adapted to serum-free culture and suspension culture, and method for preparing viruses for vaccine using cells thereof
03/15/2012WO2012033186A1 Culture method related to differentiation of pluripotent stem cells into blood cells
03/15/2012WO2012033181A1 Culture method and culture device
03/15/2012WO2012033142A1 Hepatitis c virus liposome vaccine
03/15/2012WO2012032844A1 Cell culture container and cell culture method using container
03/15/2012WO2012032763A1 Vangl1 peptides and vaccines including the same
03/15/2012WO2012032526A2 Use of anti third party central memory t cells for anti-leukemia/lymphoma treatment
03/15/2012WO2012032525A2 An immunosuppressive drug combination for a stable and long term engraftment
03/15/2012WO2012032521A2 Novel methods and culture media for culturing pluripotent stem cells
03/15/2012WO2012032165A1 Method for enrichment of dna strand break-free spermatozoa and reduction of risks for abnormalities and/or aneuploidy
03/15/2012WO2012031744A1 Chimeric antigen receptors with an optimized hinge region
03/15/2012WO2012031374A1 Blood markers for diagnosing epithelium derived cancers and monoclonal antibodies thereof
03/15/2012WO2012009581A3 Pharmaceutical compositions comprising gingiva-derived mesenchymal stem cells and methods of treating inflammation, wound healing and contact hypersensitivity
03/15/2012WO2012007078A3 Cell culture and process for preparing the same
03/15/2012WO2012005876A3 Compositions and methods for stimulating magp-1 to improve the appearance of skin
03/15/2012WO2011159726A3 Reprogramming of cells to a new fate
03/15/2012WO2011158125A3 Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells
03/15/2012WO2011156762A8 Attractant compositions for weevils of the genus otiorhynchus and uses thereof
03/15/2012WO2011153981A3 Method for producing an organ replica, in particular a functional model
03/15/2012WO2011153348A3 Composition and method for inner ear sensory hair cell regeneration and replacement
03/15/2012WO2011130331A3 Detection and quantification of cellular stress response resolution pathway expression and functionality and the effects of agents or conditions thereupon
03/15/2012WO2011118954A3 Method for differentiating cartilage cells, bone cells, nerve cells or fat cells from human inferior turbinate mesenchymal stromal cells
03/15/2012WO2003041560A3 Compounds and methods for treatment and diagnosis of chlamydial infection
03/15/2012US20120066796 Novel 7s-alpha regulatory elements for expressing transgenes in plants
03/15/2012US20120066795 Plant Promoter Operable in Basal Endosperm Transfer Layer of Endosperm and Uses Thereof
03/15/2012US20120066794 Increased Seed Oil and Abiotic Stress Tolerance Mediated by HSI2
03/15/2012US20120066793 Methods and compositions for controlling plant pests
03/15/2012US20120066792 Novel Genes Involved In Biosynthesis
03/15/2012US20120066791 Rice transgenic event 17314 and methods of use thereof
03/15/2012US20120066788 Wild Rocket Cultivar Tricia
03/15/2012US20120066787 Transgenic plants with enhanced agronomic traits
03/15/2012US20120066786 Lettuce cultivar rio bravo
03/15/2012US20120066785 Pepper hybrid ps11423700
03/15/2012US20120066784 Cucumber Hybrid Macario
03/15/2012US20120066781 Phytases, nucleic acids encoding them and methods for making and using them
03/15/2012US20120066780 Humanized nsg mouse, method of producing the same and use thereof
03/15/2012US20120066778 Control of uric acid homeostasis
03/15/2012US20120066776 Identification of a jak2 mutation involved in vaquez polyglobulia
03/15/2012US20120065574 Isoform nell-1 peptide
03/15/2012US20120065385 Dendritic cell co-stimulatory molecules
03/15/2012US20120065380 Dual targeting antibody of novel form, and use thereof
03/15/2012US20120065374 Dendritic cell co-stimulatory molecules
03/15/2012US20120065252 Engineered nucleic acids and methods of use thereof
03/15/2012US20120065251 Mir-21 promoter driven targeted cancer therapy
03/15/2012US20120065248 Methods and compositions involving mirna and mirna inhibitor molecules
03/15/2012US20120065247 Modulating ires-mediated translation
03/15/2012US20120065243 Rna duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
03/15/2012US20120065171 Fostriecin derivatives and the pharmaceutical uses thereof
03/15/2012US20120065138 Lipids, lipid complexes and use thereof
03/15/2012US20120065136 Recombinant factor viii having enhanced stability following mutation at the a1-c2 domain interface
03/15/2012US20120065129 Method of mass producing growth factor using adipose derived adult stem cells
03/15/2012US20120065106 Methods and Compositions for Enhanced Protein Expression and Purification
03/15/2012US20120065101 Methods for regulating neural differentiation
03/15/2012US20120064631 Method for amplification and high-level expression of target gene in mammalian cell, and kit for achieving the method
03/15/2012US20120064630 Eukaryotic host cell comprising an expression enhancer
03/15/2012US20120064629 Variant isoprenoid producing enzymes and uses thereof
03/15/2012US20120064628 Tubular scaffold for neural growth
03/15/2012US20120064627 Apparatus and method for culturing stem cells
03/15/2012US20120064626 B7-h7 antibodies and method of use
03/15/2012US20120064625 Nucleic Acids, Polypeptides, Compositions, and Methods for Modulating Apoptosis
03/15/2012US20120064624 Method for inhibiting the growth of mycobacterium tuberculosis by using cd13 receptor
03/15/2012US20120064623 Process for the Culturing of Cells
03/15/2012US20120064622 Methods and Systems for Chemoautotrophic Production of Organic Compounds
03/15/2012US20120064621 Cell Culture Compositions Capable of Producing a VEGF-Binding Fusion Polypeptide
03/15/2012US20120064604 Methods for enhancing infectivity of retroviruses
03/15/2012US20120064603 Selective access to cryopreserved samples
03/15/2012US20120064598 Mutation of the parkin gene, compositions, methods and uses
03/15/2012US20120064580 Termite enzymes and uses thereof for in vitro conversion of lignin-containing materials to fermentable products
03/15/2012US20120064578 Chromosome-based platforms
03/15/2012US20120064577 Mutant T7 polymerases
03/15/2012US20120064571 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
03/15/2012US20120064570 Novel cell penetrating peptide
03/15/2012US20120064568 Endomannosidases in the modification of glycoproteins in eukaryotes
03/15/2012US20120064548 Novel genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
03/15/2012US20120064544 Methods of Diagnosing Hypophosphatemic Disorders
03/15/2012US20120064542 Monoclonal antibodies and detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid
03/15/2012US20120064541 N-glycan core beta-galactosyltransferase and uses thereof
03/15/2012US20120064537 Use of perfusion decellularized organs for matched recellularization
03/15/2012US20120064524 Tumor suppressor gene, p47ing3
03/15/2012US20120064518 Methods, tip assemblies and kits for introducing material into cells
03/15/2012US20120064505 Measurement of material properties and related methods and compositions
03/15/2012US20120064122 Treatment of autoimmune inflammation using mir-155
03/15/2012US20120064121 Pyridine compounds for inflammation and immune-related uses
03/15/2012US20120064117 Tetravalent influenza vaccine and use thereof
03/15/2012US20120064115 Recombinant virus-like particles encoded by multi-gene vector
03/15/2012US20120064112 Recombinant newcastle disease viruses useful as vaccines or vaccine vectors
03/15/2012US20120064106 Flagellin fusion proteins and use thereof to induce immune responses against pseudomonas aeruginosa
03/15/2012US20120064100 Biomarkers and uses thereof
03/15/2012US20120064099 Compounds that inhibit nfkb and bace1 activity
03/15/2012US20120064096 BTLA Antibodies and Uses Thereof
03/15/2012US20120064093 Antibody
03/15/2012US20120064084 Signal transduction protein tab2
03/15/2012US20120064081 Anti-kir3d antibodies
03/15/2012US20120064080 Human LY6-Big Molecules and Methods of Use
03/15/2012US20120064078 Novel Tumor Biomarket
03/15/2012US20120064077 Stable and soluble antibodies inhibiting tnf alpha
03/15/2012US20120064073 Il-17 homologous polypeptides and therapeutic uses thereof